Literature DB >> 18600325

Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura.

Daoxin Ma1, Xiaojuan Zhu, Ping Zhao, Chunhong Zhao, Xiaofang Li, Yuanyuan Zhu, Lizhen Li, Jianzhi Sun, Jun Peng, Chunyan Ji, Ming Hou.   

Abstract

The data on polarization of the immune system towards T helper 1 (Th1) or T helper 2 (Th2) cells in immune thrombocytopenic purpura (ITP) are limited and contradictory. Th17 characterized by the production of Interleukin 17 (IL-17) has been shown to play a crucial part in the induction of autoimmune diseases. To further investigate the role of Th cytokines in the pathogenesis of ITP, we measured the plasma concentration of three Th17-associated cytokines [IL-17, transforming growth factor-ss (TGF-ss), IL-6] and Th1 cytokine interferon-gamma (IFN-gamma) in ITP patients, and evaluated their clinical relevance. The concentration of IL-17, TGF-ss, IL-6, and IFN-gamma in plasma specimens from 29 adults with chronic ITP and 38 controls was analyzed by enzyme-linked immunosorbent assay method. No significant differences of Th17 cytokines (IL-17, TGF-ss, and IL-6) and Th1 cytokine (IFN-gamma) concentration were observed between patients with active ITP and the control group. And the IFN-gamma/IL-17 ratio representing Th1/Th17 cytokine profile was not significantly different between ITP patients and control, either. However, significantly positive correlation between IL-6 and IFN-gamma in ITP patients was observed (r = 0.48, P = 0.01). Among the ITP patients, Plasma IL-17 levels in male were marginally higher than those in female, while similar for TGF-ss, IL-6 or IFN-gamma. There was a significantly positive correlation between age and IL-6 concentration in ITP patients (r = 0.56, P = 0.0002), while no statistical significance between age and the other three cytokines. No significant correlation between cytokine concentrations and platelets or megakaryocytes number was found in ITP patients. In summary, ITP may not be associated with changes of plasma Th17 and Th1 cytokine concentrations relative to control population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600325     DOI: 10.1007/s00277-008-0535-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  25 in total

Review 1.  Interleukin 17 in vascular inflammation.

Authors:  Sibylle von Vietinghoff; Klaus Ley
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

2.  Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia.

Authors:  Jiang Cao; Chong Chen; Li Li; Zeng Ling-yu; Li Zhen-yu; Yan Zhi-ling; Chen Wei; Cheng Hai; Wei Sang; Xu Kai-lin
Journal:  J Clin Immunol       Date:  2012-06       Impact factor: 8.317

3.  Circulating CD4+CD161+CD196+ Th17 cells are not increased in immune thrombocytopenia.

Authors:  Daria Sollazzo; Sara Trabanelli; Antonio Curti; Nicola Vianelli; Roberto Massimo Lemoli; Lucia Catani
Journal:  Haematologica       Date:  2011-02-28       Impact factor: 9.941

4.  Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice.

Authors:  B M Johnson; M-C Gaudreau; M M Al-Gadban; R Gudi; C Vasu
Journal:  Clin Exp Immunol       Date:  2015-08       Impact factor: 4.330

5.  The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia.

Authors:  Andreia Maria Camargos Rocha; Cláudia Souza; Gifone Aguiar Rocha; Fabrício Freire de Melo; Nelma Cristina Diogo Clementino; Marília Campos Abreu Marino; Adriana Bozzi; Maria Luiza Silva; Olindo Assis Martins Filho; Dulciene Maria Magalhães Queiroz
Journal:  Haematologica       Date:  2011-10       Impact factor: 9.941

Review 6.  Clinical updates in adult immune thrombocytopenia.

Authors:  Michele P Lambert; Terry B Gernsheimer
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

7.  Gender bias in lupus: does immune response initiated in the gut mucosa have a role?

Authors:  M-C Gaudreau; B M Johnson; R Gudi; M M Al-Gadban; C Vasu
Journal:  Clin Exp Immunol       Date:  2015-04-29       Impact factor: 4.330

8.  Implication of Th17 and Th1 cells in patients with chronic active hepatitis B.

Authors:  Jian Ge; Kai Wang; Qing-Hua Meng; Zhao-Xia Qi; Fan-Li Meng; Yu-Chen Fan
Journal:  J Clin Immunol       Date:  2009-09-10       Impact factor: 8.317

Review 9.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

10.  The role and mechanism of miR-557 in inhibiting the differentiation and maturation of megakaryocytes in immune thrombocytopenia.

Authors:  Yan Wang; Yujie Guo; Xiaolei Zhang; Hui Zhao; Bingbing Zhang; Yi Wu; Jingyu Zhang
Journal:  RNA Biol       Date:  2021-02-15       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.